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nthony J. White, MBBS, PHD,* Gautam Kedia, MD,* James M. Mirocha, MS,*
ichael S. Lee, MD,† James S. Forrester, MD,* Walter C. Morales, BS,*
uhail Dohad, MD,* Saibal Kar, MD,* Lawrence S. Czer, MD,* Gregory P. Fontana, MD,*
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os Angeles, California
bjectives The purpose of this study was to compare outcomes for drug-eluting stents (DES) and
oronary artery bypass graft (CABG) surgery in patients with unprotected left main coronary artery
ULMCA) stenosis.
ackground Expert guidelines recommend coronary artery bypass graft (CABG) surgery for the
reatment of signiﬁcant stenosis of the unprotected left main coronary artery (ULMCA) if the patient
s eligible for CABG; however, treatment by percutaneous coronary intervention (PCI) is common.
ethods Details of patients (n  343, ages 69.9  11.9 years) undergoing coronary revasculariza-
ion for ULMCA stenosis (April 2003 to January 2007) were recorded. A total of 223 patients were
reated with CABG (mean [interquartile range]: follow-up 600 [226 to 977) days) and 120 by PCI
follow-up 362 [192 to 586) days). The hazard ratios (HRs) for death and major adverse cardiovascu-
ar and cerebrovascular events (MACCE) were calculated incorporating propensity score adjustment.
urvival comparisons were conducted in propensity-matched subjects (n  134), and in low- and
igh-risk subjects for CABG.
esults Patients treated by PCI were more likely to be 75 years of age (49% vs. 33%; p  0.005),
nd of greater surgical risk (Parsonnet score 17.2  11.2 vs. 13.0  9.3; p  0.001) than patients
reated by CABG. Overall, the propensity-adjusted HR for death was not statistically different (HR
.93, 95% conﬁdence interval [CI] 0.89 to 4.19, p  0.10), but MACCE was greater in the PCI group
HR 1.83, 95% CI 1.01 to 3.32, p  0.05). In propensity-matched individuals, neither survival nor
ACCE-free survival were different. Survival was equivalent among low-risk candidates, but PCI had
tendency to inferior survival in high-risk candidates (Ellis category IV, log-rank p  0.05). Interac-
ion testing, however, failed to demonstrate a difference in outcomes of the 2 revascularization
echniques as a function of baseline risk assessment.
onclusions Overall, the propensity-adjusted risk of mortality for treatment of ULMCA disease does
ot differ between PCI- and CABG-treated groups. There appears to be sufﬁcient equipoise that a
andomized clinical trial to compare the techniques would not be ethically contraindicated. (J Am
oll Cardiol Intv 2008;1:236–45) © 2008 by the American College of Cardiology Foundation
rom *Cedars-Sinai Medical Center, University of California, Los Angeles School of Medicine, and †UCLA Division of
ardiology, Los Angeles, California. Dr. Makkar is a consultant for Cordis Corporation and has received educational grants from
oston Scientific Corporation, both makers of drug-eluting stents.anuscript received November 20, 2007; revised manuscript received February 25, 2008, accepted February 29, 2008.
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237emodynamically significant left main coronary artery ste-
osis is found in approximately 4% of diagnostic coronary
ngiograms (1) and is known as unprotected left main
oronary artery (ULMCA) stenosis if the left coronary
rtery has no previous grafts. Such anatomical pathology
ompromises perfusion to approximately two-thirds of the
yocardium and is thus an intuitively dangerous lesion.
tudies by Veteran’s Affairs (2,3), CASS (Coronary Artery
urgery Study) (4,5), and European (6) groups in the 1970s
See page 246
nd 1980s confirmed very high mortality rates among such
ndividuals and also demonstrated substantial reductions in
ortality when revascularization by coronary artery bypass
raft (CABG) surgery was undertaken (7,8). Subsequently,
he mortality benefit of CABG compared with medical
anagement for ULMCA disease was also confirmed in a
eta-analysis (9).
The beneficial treatment effect of surgery is probably even
reater in the current era because of routine use of a
ammary graft to the left anterior descending (LAD) coronary
rtery wherever possible. Current practice guidelines do not
ecommend percutaneous coronary intervention (PCI) for
evascularization for ULMCA stenosis if the patient is a
andidate for CABG (10,11) because of the proven benefit of
urgery, high rates of restenosis with use of bare-metal stents in
he LMCA position (12–14), and concern that restenosis may
resent with sudden death rather than angina in this anatomic
ocation (13). If a patient with ULMCA stenosis is a candidate
or revascularization, but not for CABG, the guidelines con-
ider PCI of the lesion reasonable (Class IIa indication) (10).
Approximately 20% of ULMCA revascularizations in the
.S. are currently performed by PCI (15). Treatment of
LMCA stenosis with PCI is often undertaken in the best
nterests of individuals, where the risk of CABG would be
nacceptably high, or in patients who refuse to undergo a
ternotomy. The advent of drug-eluting stents (DES), and
onrandomized data that suggest the long-term outcomes
f DES to treat ULMCA stenoses are acceptable (16–19)
ave led some cardiologists to consider the possibility of a
roader role for PCI as a treatment option for ULMCA
tenosis.
Randomized procedural and outcomes data that compare
ABG and PCI using DES for treatment of ULMCA
tenosis would be a great advance in our clinical knowledge
ut no such dataset exists. With the advent of DES and
ith increasing appreciation of neuropsychiatric deficits
fter cardiac surgery (20), such a trial is now considered by
any to be not only ethical but in fact highly warranted
21). When completed and published, the SYNTAX trial
Synergy between PCI and Taxus and Cardiac Surgery) of
ABG versus DES will have a subset of individuals with RLMCA stenosis available for analysis to shed some light
n this question.
In this context, we analyzed the results of ULMCA
tenosis revascularization procedures and outcomes from
edars-Sinai Medical Center, Los Angeles, California,
ince the introduction of DES. We used propensity scoring,
hich is a statistical technique that models an individual’s
ropensity (or probability) of belonging to a certain group
for example, treatment by CABG or PCI). The effect of
ncorporation of the propensity score is to balance subject
haracteristics in the 2 groups (22,23). In the absence of
andomized data, this technique may be the closest we can
et to a fair comparison of the 2 revascularization techniques
or ULMCA stenosis.
ethods
tudy population. Three hun-
red forty-three patients with
LMCA diameter stenosis who
ere revascularized at our insti-
ution during the time period of
pril 2003 to January 2007 were
ncluded in this observational
tudy . The definit ion of
LMCA stenosis used for in-
lusion in this prospective regis-
ry was angiographic diameter
tenosis of greater than 50% rel-
tive to a reference segment of
he left main coronary artery.
ndividuals who had valve re-
lacement surgery concomi-
antly with revascularization sur-
ery, and individuals who had a
are-metal stent placed in the
eft main position were excluded
rom this prospective registry. Choice of revascularization
echnique was a nonrandomized process that involved eval-
ation and advice from treating doctors, and discussions
ith patient and family. Two hundred twenty-three patients
nderwent CABG, and 120 underwent PCI with DES
Fig. 1). In keeping with published guidelines (10), individ-
als generally underwent CABG unless their cardiac sur-
eon or cardiologist advised against CABG on the basis of
igh surgical risk, or the patient, with their family, had a
trong preference not to undergo cardiac surgery.
The primary end points were the hazard ratio (HR) for
eath and the HR for major adverse cardiovascular and
erebrovascular events (MACCE) using a Cox proportional
azards model that incorporated propensity score as a
ovariate. This study was approved by the Institutional
Abbreviations
and Acronyms
CABG  coronary artery
bypass graft (surgery)
CI  confidence interval
DES  drug-eluting stent(s)
HR  hazard ratio
IABP  intra-aortic balloon
pump
LAD  left anterior
descending (coronary artery)
MACCE  major adverse
cardiovascular and
cerebrovascular event
PCI  percutaneous
coronary intervention
ULMCA  unprotected left
main coronary arteryeview Board of Cedars-Sinai Medical Center.
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238alculation of surgical risk estimates. Subgroup analysis was
onducted by the use of 2 multivariate models of cardiac
perative risk estimation, the Parsonnet (24) and Ellis (25)
cores, to divide patients into high and low estimated risk
ategories. The Parsonnet score is a points-based additive
odel that uses 15 variables with various assigned weights
24): female gender (1 point); pre-operative intra-aortic
alloon pump (IABP; 2 points); obesity, diabetes, and
ypertension (3 points each); left ventricular aneurysm (5
oints); emergency surgery after catheterization lab compli-
ations or dialysis dependency (10 points each); ejection
raction (50%, 0 points; 30% to 49%, 2 points; 30%, 4
oints); age (70 years, 0 points; 70 to 74 years, 7 points;
5 to 79 years, 12 points; 80 years, 20 points); and
eoperation (first, 5 points; second, 10 points). Another 3
omponents of the model relate to concomitant valve
urgery, which was not relevant to the current study popu-
ation. A patient with a Parsonnet score  15 was consid-
red to have low surgical risk, and a patient with a Parsonnet
core 15 was considered to be at high surgical risk.
The Ellis score is another validated points-based cardiac
urgical risk estimation model (25). Points are allocated for
hronic obstructive pulmonary disease (2 points), renal
nsufficiency (3 points), age 60 to 69 years (3 points), age 70
o 79 years (6 points), or age older than 80 years (9 points).
ndividuals are then allocated to an Ellis score category,
ased on their score as follows: category I (0 points),
ategory II (1 to 3 points), category III (5 to 6 points) and
ategory IV (7 points), with a higher category implying a
igher surgical risk.
CI. Percutaneous coronary intervention was performed
343 consecutive patients with ULMCA stenosis
(excluding patients that received concomitant valve surgery)
Operator Discretion / Patient Preference / Surgical Rejection
120 treated by PCI with 
drug-eluting stent(s)
223 treated by CABG
Primary endpoints: Mortality and major adverse cardiac and 
cerebrovascular events (MACCE) over the follow-up period
Figure 1. Participant Flow Through the Study
CABG  coronary artery bypass grafting; MACCE  major adverse cardio-
vascular and cerebrovascular event; PCI  percutaneous coronary interven-
tion; ULMCA  unprotected left main coronary artery.ith the use of standard vascular access, guiding catheter, (nd coronary wiring techniques. Lesions at the ostium or in
he shaft of the ULMCA were generally treated with a
ingle DES. Where there was involvement of the distal
ifurcation of the ULMCA, the judgment of the primary
perator was used to decide upon an appropriate stenting
trategy. Techniques used included a single stent deployed
cross the ostium of one branch (usually the circumflex), or
se of 2 stents using a “T”, crush, or kissing stent technique.
he choice of sirolimus- or paclitaxel-eluting stent was at
he operator’s discretion and not mandated by the study
rotocol. Intra-vascular ultrasound was routinely used to
heck for adequate stent apposition to the vessel wall, unless
n adverse hemodynamic situation made this imaging mo-
ality dangerous. Aspirin and clopidogrel were commenced
efore the procedure. Aspirin was continued indefinitely
nd clopidogrel recommended for a minimum of 6 months.
ardiac enzymes were measured post-procedure if there was
linical suspicion of ischemia, but were not measured
outinely. Periprocedural IABP and glycoprotein IIb/IIIa
ntagonist infusions were used at the operator’s discretion.
ABG. Standard techniques for sternotomy, cardioplegia,
rterial harvest, and anastamoses and wound closure were
sed. Arterial conduits were preferred to saphenous vein
rafts, and in particular an internal mammary artery was
nastamosed to the LAD whenever possible.
ACCE. Major adverse cardiovascular and cerebrovascular
vents was a composite of death, myocardial infarction,
epeat revascularization, and stroke. The intense focus
urrently on the incidence of late acute stent thrombosis
ollowing implantation of DES is noted (26,27), but be-
ause full importance of this issue was not appreciated at the
ommencement of this registry, data on occurrence of acute
tent thrombosis was not specifically prospectively collected
n this study. Such events would however have been likely to
e detected as one of the MACCE component events.
tatistical methods. Data are presented as mean SD or as
ercentages, except where indicated. Comparison of cate-
orical variables was performed with the use of chi-square or
ishers exact tests as appropriate, and normally distributed
ontinuous variables were compared with the use of t tests.
omparisons of Kaplan-Meier survival curves were made by
pplying the log-rank test.
A multivariate logistic regression analysis that uses 18
ariables was used to develop a model of propensity score, to
stimate the probability that a given individual in this study
as treated with CABG. This was done in an effort to take
nto the account the different characteristics of the groups
hat were inevitably present by virtue of the clinical
ecision-making process. The power of the model to predict
roup membership for a given individual was assessed by the
-statistic (similar to area under the curve of a receiver-
perator characteristic of a test). The 18 variables used to
onstruct the propensity score consisted of 15 categorical
yes/no) and 3 continuous pre-treatment variables. The
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239ategorical variables were the presence/absence of age 75
ears, male gender, diabetes (defined by use of insulin or oral
ypoglycemic agents), hypertension, chronic renal impair-
ent (defined by a serum creatinine of 1.5 mg/dl in the
bsence of an identified reversible cause), chronic obstruc-
ive pulmonary disease, hypercholesterolemia, history of
yocardial infarction, history of coronary artery disease
defined as previous electrocardiogram, enzyme, perfusion
r angiographic evidence of coronary artery disease), pre-
entation with unstable angina, presentation with stable
ngina, presentation with myocardial infarction, involve-
ent of distal left main coronary artery, right coronary
rtery stenosis, and Ellis score category III or IV (vs. I or II).
he continuous variables were age, serum creatinine, and
arsonnet score.
This propensity score was used in 2 ways. First, the
ropensity score was used as a covariate in a Cox propor-
ional hazards model for death and for MACCE to derive
Rs for the primary end points. Second, the propensity
core was used to construct Kaplan-Meier curves for free-
om from death and freedom from MACCE using the
ubset of patients that could be matched for propensity score
ithin 0.03 (n  67 PCI, n  67 CABG). Comparisons
etween these propensity-matched treatment groups were
ade by the log-rank test. Interaction tests were performed
o investigate whether treatment effects differed as a func-
ion of initial surgical risk as assessed by Parsonnet score or
llis category. All statistical tests were 2-tailed. A value of
 0.05 was used to determine statistical significance.
esults
aseline characteristics. Three hundred forty-three patients
ith ULMCA stenosis were treated (age 69.9  11.9 years,
0.3% male gender): 223 with CABG and 120 with PCI
sing a DES (Table 1). As compared with those treated
ith CABG, a greater proportion of patients treated with
CI were ages 75 years or older (49% vs. 33%; p  0.005)
nd a lower proportion were men (58% vs. 77%; p 0.001).
atients treated with PCI were also less likely to have
resented with stable angina (27% vs. 45%; p  0.001) and
ad a greater Parsonnet score (17.3  11.3 vs. 13.0  9.3;
 0.001) than those treated with CABG. A greater
roportion of patients treated with CABG had additional
isease of the right coronary artery (71% vs. 28%; p 
.0001) and/or presence of stenosis involving the bifurca-
ion of the left main coronary artery (77% vs. 64%; p 
.01) than those treated with PCI.
Within the PCI group, 50 patients (41.7%) had been
urned down for CABG after cardiac surgical consultation,
5 patients (20.8%) had not been referred for surgical
onsultation because they were considered to be poor
urgical candidates by their physician, and 45 patients
37.5%) preferred PCI over surgery. crocedural characteristics. Ninety-one patients (75.8%) had
irolimus-eluting stents (Cypher, Cordis Corporation, Mi-
mi Lakes, Florida) and 29 (24.2%) had paclitaxel-eluting
tents (Taxus, Boston Scientific, Natick, Massachusetts)
sed in the left main position. An average of 2.6  1.4
tents per patient, with an average total length of 49.9 
3.7 mm were implanted in these procedures (not just in the
eft main position). A total of 77 of 120 PCI patients (64%)
ad disease involving the bifurcation of the left main
oronary artery. When bifurcation disease was present, the
ollowing stenting techniques were used to deal with the
ifurcation lesion: One stent placed across the ostium of the
ircumflex into the proximal LAD, 33 (43%); 2 stents
laced by the kissing stent technique, 22 (29%); 2 stents
laced using the crush technique, 17 (22%); and 2 stents
laced using T-stenting technique, 5 (6%). Intravascular
ltrasound was used in 103 (85.8%) and glycoprotein
Ib/IIIa antagonists in 17 (14.2%) cases. Hemodynamic
upport included IABP in 58 (48.3%) cases and tandem
eart percutaneous left ventricular assist device in 3 (2.5%)
ases. Eighty-six (72%) PCI-treated patients received a
tent to a coronary lesion other than the one in the left main
Table 1. Baseline Characteristics of the Study Population
CABG PCI p Value
n 223 120
Age, yrs, mean  SD 69.4 10.7 70.9 13.9 0.31
Age 75 yrs 74 (33) 59 (49) 0.005
Gender, male 171 (77) 70 (58) 0.001
Diabetes mellitus 60 (27) 42 (35) 0.11
Hypertension 170 (76) 90 (76) 0.90
Hypercholesterolemia 171 (77) 89 (75) 0.69
Current smoker 37 (17) 21 (18) 0.76
Chronic renal insufﬁciency
1.5 mg/dl
22 (10) 21 (18) 0.06
Previous stroke 19 (9) 8 (7) 0.68
Left ventricular ejection
fraction, %
54 11 54 14 0.94
Clinical presentation 0.001
Stable angina 101 (45) 32 (27)
UA/MI/other 122 (55) 88 (73)
Parsonnet score, mean  SD 13.0 9.3 17.3 11.3 0.001
Patients with Parsonnet
score 15
82 (37) 65 (54) 0.002
Ellis score
Category I 27 (12) 25 (21) 0.001
Category II 68 (30) 19 (16)
Category III 75 (34) 30 (25)
Category IV 53 (24) 46 (38)
Data are presented as number (%) unless otherwise specified.
CABG  coronary artery bypass grafting; MI  myocardial infarction; PCI  percutaneous
coronary intervention; UA unstable angina.oronary artery.
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240Within the CABG group, the average number of grafts
as 3.0  0.8, and 215 (96.4%) of patients received a
IMA graft to the LAD. Length of stay in hospital was
onger in the CABG group than the PCI group (7.5  4.6
ays vs. 4.3  5.1 days; p  0.0001).
ollow-up. Longer follow-up was available for the CABG-
reated group compared with the PCI-treated group (me-
ian [interquartile range]: 600 [226 to 977] days vs. 362
192 to 586] days). Of the 10 target vessel revascularization
rocedures in the group initially treated with PCI, 7 were
linically driven; 9 were performed for recurrent narrowings,
nd 1 for a previously untreated coronary lesion.
ropensity analysis. Propensity analysis was performed be-
ause the treatment group characteristics were so different
Table 1) as to render comparison of raw outcome data
nreliable. The C-statistic of the propensity model was
.81. The average propensity score (where a hypothetical
core of 1 would be a certainty to be treated with CABG)
as 0.25  0.19 in the PCI group and 0.52  0.24 in the
ABG group (p  0.0001).
Propensity-matched subjects (individuals from each
roup with propensity scores within 0.03 of each other, n 
34) were found to have similar characteristics (Table 2),
roviding good evidence that propensity score was an
ffective method to account for differences between the
reatment groups. When the propensity score was entered as
covariate into a Cox proportional hazards regression
odel for death, there was no statistically significant evi-
ence for a different risk of death in the PCI versus the
ABG group (HR 1.93, 95% confidence interval [CI] 0.89
o 4.19, p 0.10). With a similar Cox proportional hazards
odel for MACCE, there was evidence of a greater risk of
ACCE in the PCI group versus the CABG group (HR
.83; 95% CI 1.01 to 3.32, p  0.05).
Propensity-matched subjects were used to construct
aplan-Meier survival curves for comparison of death-free
Fig. 2A) and MACCE-free (Fig. 2B) survival. This
ethod of analysis showed no evidence for a difference in
bsolute survival (log-rank p  0.40), and no evidence for a
ifference in MACCE-free survival (log-rank p  0.32).
utcomes according to baseline estimation of risk. Next,
aw outcome data were used to examine the influence of
aseline operative risk assessment upon survival, with the
nclusion of both the Parsonnet (24) and Ellis (25) scoring
stimates of operative risk to divide the database. Survival
as not different between CABG and PCI among individ-
als with a Parsonnet score 15 (Fig. 3A) (log-rank p 
.81), but in individuals with a Parsonnet score 15, there
as a trend toward worse survival in the PCI group than the
ABG group (Fig. 3B) (log-rank p  0.09). MACCE-free
urvival also showed a differential depending on Parsonnet
core. MACCE-free survival was not different between
ABG and PCI among individuals with a Parsonnet score
15 (Fig. 3C) (log-rank p  0.44) but in those with a aarsonnet score 15, MACCE-free survival was worse in
he PCI group (Fig. 3D) (log-rank p  0.04). Despite this
pparent divergence of clinical outcome between the 2
echniques as a function of baseline Parsonnet score, the
nteraction test for death (p 0.61) or MACCE (p 0.70)
s not significant. Thus, treatment effects did not differ as a
unction of baseline risk.
Survival was not different between CABG and PCI
mong individuals with an Ellis category of I, II, or III (Fig.
A) (log-rank p  0.60), but in individuals in Ellis category
V the PCI group had worse survival than the CABG group
Fig. 4B) (p  0.05). In neither those individuals within
llis category I, II or III (Fig. 4C) (log-rank p  0.07), nor
hose in Ellis category IV (Fig. 4D) (log-rank p 0.14) was
here a statistically significant difference in MACCE-free
urvival between the CABG and PCI groups. Interaction
esting was again performed and, similarly, there was no
tatistical evidence that PCI differentially affected the HR of
eath (interaction test, p  0.72) or MACCE (interaction
est, p 0.80) in the Ellis IV group versus the Ellis category
, II, or III group.
There was no significant difference in the HR for death
HR 1.09, 95% CI 0.40 to 2.97, log rank p  0.86)
Table 2. Characteristics of 134 Subjects Who Were Able to Be Matched
for Propensity Score Within 0.03
CABG PCI p Value
N 67 67
Age, yrs, mean  SD 72.2 11.9 68.6 13.2 0.11
Age  75 yrs 32 (48) 25 (37) 0.21
Gender, male 42 (63) 44 (66) 0.72
Diabetes mellitus 21 (31) 23 (34) 0.72
Hypertension 52 (78) 49 (73) 0.56
Hypercholesterolemia 50 (75) 52 (78) 0.68
Current smoker 8 (12) 14 (21) 0.18
Chronic renal insufﬁciency
1.5 mg/dl
9 (13) 8 (12) 0.80
Previous stroke 5 (8) 4 (6) 0.74
Left ventricular ejection
fraction, %
52.9 12.9 55.0 11.9 0.30
Clinical presentation 0.10
Stable angina 26 (39) 18 (27)
UA/MI/other 41 (61) 49 (73)
Parsonnet score, mean  SD 17.0 11.3 14.4 11.0 0.22
Patients with Parsonnet
score 15
34 (51) 26 (39) 0.16
Ellis score 0.56
Category I 9 (13) 15 (22)
Category II 14 (21) 15 (22)
Category III 20 (30) 19 (28)
Category IV 24 (36) 18 (27)
Data are presented as number (%) unless otherwise specified.
Abbreviations as in Table 1.ccording to the baseline presence of bifurcation disease of
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241he left main coronary artery in the PCI treated group.
here was a trend toward an increased HR for MACCE
HR 1.80, 95% CI 0.80 to 4.03, log rank p  0.15) if
ifurcation disease was present, though this was statistically
ot significant.
iscussion
he main finding of this study is that after accounting for
re-treatment group differences, the risk for death after
evascularization for ULMCA was not different between
CI and CABG during the follow-up period. This finding
s noted, in the context of current guidelines for manage-
ent of ULMCA by revascularization, which state that use
f PCI to treat significant ULMCA stenosis is a class III
ndication (“not effective. . .may be harmful. . .”) if the
atient is a candidate for CABG (10). In patients who are
Figure 2. Survival Curves in Propensity-Matched Individuals
There were 67 patients in the PCI group and 67 patients in the CABG
group (n  134). (A) Survival in 134 propensity-matched individuals. (B)
Major adverse cardiovascular and cerebrovascular event-free survival in 134
propensity-matched individuals. Abbreviations as in Figure 1.andidates for revascularization but are not eligible for oABG (a description that applies to a majority of the PCI
roup in this study), PCI of ULMCA stenosis is considered
easonable (class IIa indication) (10).
In contrast to similar mortality rates with either proce-
ure, MACCE-free survival calculated by the Cox propor-
ional hazards model was lower in the PCI-treated group,
ostly because of an excess of repeat revascularization
rocedures. We note that the use of the propensity score in
ways yielded different results with respect to MACCE
utcomes. The differences in the results between the 2
djustment tools may relate to the difference in sample
ize—the Cox proportional hazard method used all of the
ndividuals in the registry (n 343), whereas the propensity
atching method could use less than one-half this number
n  134). Among the methodological tools that have been
eveloped to minimize bias (confounding) in observational
tudies, propensity score-matched comparison is generally
onsidered to be the most robust.
In contrast to similar mortality rates with either proce-
ure, MACCE-free survival was lower in the PCI-treated
roup, mostly because of an excess of repeat revasculariza-
ion procedures. Of note, many physicians at our institution
cheduled follow-up angiography after PCI to the ULMCA,
ven in the absence of symptoms. This inevitably led to
reatment of newly discovered stenoses. Such nonclinically
riven repeat procedures have the potential to contribute
ystematically to MACCE events in the PCI but not the
ABG group. Nonetheless, the excess of repeat procedures
n the PCI group represents one of its principal limitations,
hich in an individual patient must be balanced against the
ecovery period following CABG.
Our higher rate of repeat revascularization procedures
fter PCI treatment is consistent with previous randomized
omparisons of PCI and CABG using bare metal stents
28–30), although not specifically in ULMCA stenosis.
estenosis appears to be an inherent trade-off for the
educed invasiveness of PCI. Our study, the first report
rom a U.S. medical center, is also broadly comparable with
Italian studies that both concluded that the mortality rates
or revascularization of ULMCA are similar with either
echnique (31,32).
The clinical cardiology community has come to accept
igher rates of target vessel revascularization associated with
reatment of multivessel disease by PCI because survival
ates are similar to CABG. However, extrapolation of these
esults to ULMCA is inappropriate because at this anatomic
ocation, restenosis could present as sudden death (13). Our
ata, therefore, provide a rational basis for use of DES in
elected patients with ULMCA because DES have substan-
ially reduced the incidence of restenosis after PCI.
Patients who were treated with PCI in this study had
igher risk characteristics than those treated with CABG
Table 1). A larger proportion of subjects ages 75 years and
lder were treated with PCI, and the Parsonnet score, a
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242ultivariable validated surgical risk predictor, was greater in
he PCI group. On the other hand, other institutions may
ave different criteria for selecting PCI or CABG. In a
ilanese group of patients revascularized for ULMCA
tenosis (31), it was the CABG-treated group with higher
isk characteristics (older, with a greater proportion with
enal failure). In our institution PCI was usually reserved for
atients felt to be at high surgical risk, in keeping with the
uidelines (10), and this clinical practice pattern is reflected
n the characteristics of the groups.
There are no published comparative long-term data
etween PCI with DES and CABG for ULMCA stenosis
rom any center in the U.S. Preliminary outcome data from
ur registry were first reported approximately 2 years ago
33). These data showed no increase in immediate compli-
ations for PCI compared with CABG. Our current report
Figure 3. Survival Curves According to Pre-Procedural Estimation of Risk b
(A) Overall survival in individuals with a Parsonnet score 15. (B) Overall surv
als with a Parsonnet score 15. (D) MACCE-free survival for individuals with atudies a larger population, and most critically, a longer lollow-up, and uses propensity analysis to minimize the
imitations of pre-treatment group differences that charac-
erized the earlier report.
The second main finding of this paper was a suggestion
hat subgrouping patients by surgical risk may have clinical
alue. We used 2 different scoring systems. Independent of
he method used, in individuals with lower “surgical risk”
he 2 revascularization techniques had raw survival out-
omes that were not different. Among those with baseline
igh surgical risk, however, there was a greater rate of
ortality in the PCI group than the CABG group. This
ifference reached statistical significance when the Ellis
ethod of risk assessment was used. It must be emphasized,
owever, that statistical interaction testing failed to dem-
nstrate a difference in outcomes of the 2 revascularization
echniques as a function of initial risk assessment. Given the
ermination of Parsonnet Score
r individuals with a Parsonnet score 15. (C) MACCE-free survival in individu-
nnet score 15. Abbreviations as in Figure 1.y Det
ival foimited power of subgroup analyses, however, we cannot
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243ompletely exclude the possibility that the 2 revasculariza-
ion techniques may provide different treatment effects in
ow- versus high-risk groups.
It is highly likely that there are selection biases for PCI
atients to be sicker and have worse outcomes and that these
iases are not fully accounted for by stratification according
o Parsonnet or Ellis risk scoring. Examples of factors that
re not captured by either of the risk scoring systems, yet
learly have the potential to influence choice of treatment
odality and/or subsequent outcome include presence of
ifurcation left main disease, presence of concomitant other
oronary lesions and an impression of patient “frailty” by the
reating physician.
Although the current guideline recommendations are
ased predominantly on experience with bare-metal stents,
ven in that era ULMCA stenting in low-risk patients had
Figure 4. Survival Curves According to Estimation of Surgical Risk by Dete
(A) Overall survival in individuals in Ellis category I, II, or III. (B) Overall surviva
category I, II, or III. (D) Freedom from MACCE for individuals in Ellis category IVood clinical outcomes. For example, in 187 patients (age t6.2  11.2 years, 68% male) with normal ejection fraction
62.4  8.3%) there was a 97.7% cumulative probability of
ardiac death-free survival over 5 years of follow-up (34)
although there was a 21% target lesion revascularization
ate over that time). Similarly, in the ULTIMA registry
12), low-risk patients (65 years, left ventricular ejection
raction 30%, and not in cardiogenic shock) had good
utcomes (1-year actuarial outcomes; 3.4% death, 16.9%
eath/MI/CABG).
The outcome differences we observed between PCI and
ABG in the high-risk category become apparent at about
months. Because interaction testing ruled out an effect of
aseline Parsonnet or Ellis score upon the CABG/PCI
ifferential outcomes, an alternative and equally plausible
xplanation is that the curves validate physicians’ intuitive
nd experiential judgment in predicting survival, and that
tion of Ellis Category
dividuals in Ellis category IV. (C) Freedom from MACCE for individuals in Ellis
reviations as in Figure 1.rmina
l for inhe results reflect the appropriate allocation of sicker pa-
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244ients to the less invasive treatment (PCI) despite the
uidelines.
Although propensity scoring is a recognized technique
hat can be used to correct for baseline differences, it is not
substitute for a large prospective trial with extended
ollow-up that randomizes individuals to CABG or DES
or ULMCA stenosis. Such a trial could answer the ques-
ion of whether DES PCI is noninferior to CABG for
LMCA stenosis within a particular patient population but
ight not predict outcomes in clinical practice. Thus, each
ype of data analysis, registry, and randomized trial is
aluable to fully analyze the relative merits of the 2 proce-
ures. Although we failed to detect an influence of bifur-
ation left main disease on clinical outcome, we are aware
hat others have demonstrated that this variable is a predic-
or of outcome (35), and we also noted a trend in this
irection.
onclusions
ur data suggest that the propensity-adjusted risk of
ntermediate-term mortality is similar for the treatment of
LMCA stenosis by PCI with DES or CABG, although
e certainly cannot recommend widespread adoption of this
ractice on the basis of the current data. A randomized
linical trial to compare the techniques, adequately powered
o detect a mortality difference, would have considerable
ogistical and financial barriers, but appears not to be
thically contraindicated.
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